Patent details
EP2425250 Title: METHODS FOR MONITORING THE EFFICACY OF ANTI-IL-2R ANTIBODIES IN MULTIPLE SCLEROSIS PATIENTS
Basic Information
- Publication number:
- EP2425250
- PCT Application Number:
- PCT/US/2010/032572
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP107164501
- PCT Publication Number:
- WO/2010/126890
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- METHODS FOR MONITORING THE EFFICACY OF ANTI-IL-2R ANTIBODIES IN MULTIPLE SCLEROSIS PATIENTS
- French Title of Invention:
- PROCÉDÉS DE SURVEILLANCE DE L'EFFICACITÉ D'ANTICORPS ANTI-IL-2R CHEZ DES PATIENTS ATTEINTS DE SCLÉROSE EN PLAQUES
- German Title of Invention:
- VERFAHREN ZUR ÜBERWACHUNG DER EFFIZIENZ VON ANTI-IL-2R ANTIKÖRPERN IN MULTIPLE SKLEROSE PATIENTEN
- SPC Number:
Dates
- Filing date:
- 27/04/2010
- Grant date:
- 26/02/2014
- EP Publication Date:
- 26/02/2014
- PCT Publication Date:
- 04/11/2010
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 07/03/2012
- EP B1 Publication Date:
- 26/02/2014
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 27/04/2014
- Expiration date:
- 27/04/2030
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 27/04/2010
- Name:
- AbbVie Biotherapeutics Inc.
- Address:
- 1500 Seaport Boulevard, Redwood City, CA 94063, United States (US)
Inventor
- Name:
- SHERIDAN III James Peter
- Address:
- United States (US)
Priority
- Priority Number:
- 173138 P
- Priority Date:
- 27/04/2009
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- G01N 33/50;
| Filing date | Document type | Number of pages |
|---|